Medicine, Rheumatology Division

Grants

Grants per year 1993 2002 2007 2008 2011 2013 2014 2015 2016 2017 2018 2019 2027

• 1 Not started
• 73 Active
• 370 Finished

Grants per year

Search results

• Finished

  Prot #AMP-002: A Randomized, Double-Blind, Active Comparator-Controlled, Crossover Study to Assess the Capacity of Delayed-Release Prednisone (RAYOS®) Compared to Immediate-Release Prednisone to Improve Fatigue and Control Morning Symptoms in Subjects wit

  Mahieu, M. A.

  AMPEL BioSolutions, LLC

  9/5/17 → 6/1/21

  Project: Research project

• Algorithms to Identify Systemic Lupus from Electronic Health Record Data

  Kho, A. N., Ramsey-Goldman, R., Walunas, T. L. & Walunas, T. L.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/1/17 → 1/31/20

  Project: Research project

  • Health 100%
  • Health care 55%
  • Machine learning 26%
  • Throughput 12%
  • Economics 11%

• National Lupus Outreach and Clinical Trail Education Program (Lupus program)-LUPUS CONVERSATIONS Project

  Ramsey-Goldman, R. & Chmiel, J. S.

  Office of the Assistant Secretary for Health

  7/1/17 → 12/31/18

  Project: Research project

  • American 100%
  • conversation 97%
  • health professionals 59%
  • health 58%
  • social support 52%

• Uncovering the molecular mechanisms of human macrophages in pulmonary fibrosis

  Winter, D. R., Bharat, A. & Bharat, A.

  American Lung Association

  7/1/17 → 6/30/20

  Project: Research project

  • Pulmonary Fibrosis 100%
  • Macrophages 86%
  • Systemic Scleroderma 84%
  • Lung 66%
  • Interstitial Lung Diseases 27%

• Understanding the role of macrophages in the pathogenesis of rheumatoid arthritis

  Perlman, H. R., Mandelin, A. M. & Ruderman, E. M.

  Rheumatology Research Foundation

  7/1/17 → 6/30/19

  Project: Research project

  • Rheumatoid Arthritis 100%
  • Macrophages 96%
  • Synovial Membrane 47%
  • Population 31%
  • Therapeutics 13%

• Inflammatory arthritis: mechanistic insights into initiation and progression

  Pope, R. M., Bi, Y., Fang, D., Huang, Q., Misharin, A., Perlman, H. R. & Winter, D. R.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/1/17 → 5/31/22

  Project: Research project

  • Rheumatoid Arthritis 100%
  • Arthritis 91%
  • Macrophages 46%
  • Dendritic Cells 39%
  • Autoantibodies 30%

• Comparing the Regulatory Networks Underlying Inflammation in Arthritis & Aging

  Winter, D. R.

  Arthritis National Research Foundation

  6/1/17 → 5/31/19

  Project: Research project

  • Arthritis 100%
  • Rheumatoid Arthritis 69%
  • Chromatin Immunoprecipitation Sequencing 53%
  • Monocytes 51%
  • Inflammation 39%

• Prot #WI223665: A Novel Treatment Approach for Rheumatoid Arthritis

  Stehlik, C.

  Pfizer Inc.

  4/8/17 → 3/15/19

  Project: Research project

• Monocyte differentiation by Wnt/beta-catenin signaling in Systemic Sclerosis Interstitial Lung Disease

  Lam, A. P. & Hinchcliff, M. E.

  Scleroderma Foundation

  4/1/17 → 3/31/19

  Project: Research project

  • Catenins 100%
  • Systemic Scleroderma 90%
  • Interstitial Lung Diseases 69%
  • beta Catenin 56%
  • Lung 50%

• Role of Oscar in leukocyte secretion of TNF-alpha in patients with rheumatoid arthritis

  Perlman, H. R., Pope, R. M. & Ruderman, E. M.

  Indiana University, Strategic Pharma-Academic Research Consortium

  3/1/17 → 2/28/19

  Project: Research project

• Supplement: Macrophage Modulation of Lung Fibrosis

  Perlman, H. R.

  National Heart, Lung, and Blood Institute

  2/1/17 → 7/31/21

  Project: Research project

  • Alveolar Macrophages 100%
  • Fibrosis 76%
  • Macrophages 76%
  • Systemic Scleroderma 73%
  • Monocytes 64%

• Macrophage Modulation of Lung Fibrosis

  Perlman, H. R., Bagheri, N., Bharat, A., Bhorade, S. M., Budinger, G. S., Hinchcliff, M. E., Misharin, A. & Peter, M. E.

  National Heart, Lung, and Blood Institute

  2/1/17 → 7/31/21

  Project: Research project

  • Alveolar Macrophages 100%
  • Fibrosis 76%
  • Macrophages 76%
  • Systemic Scleroderma 73%
  • Monocytes 64%

• An Innovative Therapy for Systemic Sclerosis Using FDA-approved Immune-modifying Nanoparticles

  Miller, S. D., Varga, J. & Bhattacharyya, S.

  Northwestern Memorial Hospital

  1/1/17 → 12/31/18

  Project: Research project

  • Systemic Scleroderma 100%
  • Investigational Therapies 59%
  • Nanoparticles 42%
  • Monocytes 30%
  • Macrophages 19%

• The regulatory networks of human macrophages in healthy and fibrotic lungs

  Winter, D. R. & Bharat, A.

  Northwestern Memorial Hospital

  1/1/17 → 12/31/17

  Project: Research project

  • Macrophages 100%
  • Lung Diseases 86%
  • Lung 76%
  • Pulmonary Fibrosis 37%
  • Sclerosis 34%

• A novel treatment approach for inflammatory bowel disease

  Stehlik, C.

  Pfizer Inc.

  12/23/16 → 12/23/19

  Project: Research project

• IPA for Seok-Jo Kim

  Kamp, D. W. & Kim, S.

  Jesse Brown VA Medical Center

  11/1/16 → 9/30/18

  Project: Research project

  • Asbestos 100%
  • Alveolar Epithelial Cells 57%
  • Veterans 35%
  • Lung Diseases 30%
  • Lung Neoplasms 26%

• Hoellen Family Foundation Biopsy Supplies

  Perlman, H. R.

  Hoellen Family Foundation

  11/1/16 → 5/31/17

  Project: Research project

  • purchase 100%

• Sirtuins: novel determinants and therapeutic target in systemic sclerosis

  Varga, J., Agrawal, R., Davuluri, R. V., Lee, J., Tourtellotte, W. & Wei, J.

  National Institute on Aging

  9/30/16 → 6/30/19

  Project: Research project

  • Sirtuins 100%
  • Systemic Scleroderma 74%
  • Fibrosis 26%
  • Fibroblasts 13%
  • Therapeutics 7%

• Prot #XmAb5871-04: A Randomized, Double-Blinded, Placebo-Controlled Study of the Effect of XmAb®5871 on Systemic Lupus Erythematosus Disease Activity

  Ramsey-Goldman, R.

  PPD Investigator Services, LLC, Xencor, Inc.

  9/13/16 → 9/13/19

  Project: Research project

• Development of a Novel RA/Atherosclerosis Mouse Model

  Perlman, H. R., Misharin, A. & Vaughan, D. E.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/1/16 → 8/31/19

  Project: Research project

• Knee OA: Predictors and Outcomes of Physical Inactivity-Activity Transitions

  Dunlop, D. D., Chang, R. W., Lee, J. & Sharma, L.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/1/16 → 2/28/19

  Project: Research project

• Contribution of Adipocytes and Adipose Secreted Factors to Fibrosis in Systemic Sclerosis

  Korman, B. D.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/1/16 → 7/31/21

  Project: Research project

  • Fibrosis 100%
  • Adipocytes 88%
  • Systemic Scleroderma 88%
  • Skin 71%
  • Adipose Tissue 45%

• RHLCCC: Flow Cytomery Facility

  Goolsby, C. L., Swaminathan, S. & Perlman, H. R.

  National Cancer Institute

  8/1/16 → 7/31/18

  Project: Research project

• MCRC/Project 2

  Sharma, L., Acosta, A., Chang, A. H., Chmiel, J. S., Dunlop, D. D. & Moisio, K. C.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/1/16 → 7/31/19

  Project: Research project

• NIAMS Multidisciplinary Clinical Research Center in Rheumatology

  Sharma, L., Acosta, A., Chang, R. W., Chang, A. H., Chmiel, J. S., Dunlop, D. D., Lee, J., Majka, D. S., Moisio, K. C., Pope, R. M., Ramsey-Goldman, R., Spring, B. & Van Horn, L.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/1/16 → 7/31/19

  Project: Research project